| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |